Filing Details
- Accession Number:
- 0001628280-25-000994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-08 20:03:47
- Reporting Period:
- 2025-01-08
- Accepted Time:
- 2025-01-08 20:03:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197020 | L Vicki Sato | C/O Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-08 | 10,960 | $12.52 | 1,312,391 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024.
Billionaire Hedge Funds
